C07C 311/55
Having sulfur atoms of the sulfonylurea groups bound to acyclic carbon atoms
Official title: having sulfur atoms of the sulfonylurea groups bound to acyclic carbon atoms
C07C311/55 (Having sulfur atoms of the sulfonylurea groups bound to acyclic carbon atoms) appears on 45 US grants and 23 published applications in this corpus.
Search patents in C07C- Granted patents
- 45
- Published applications
- 23
- Assignees
- 27
- Inventors
- 85
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 1 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 3 | 1 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 3 |
| 2018 | 0 | 0 |
| 2019 | 4 | 0 |
| 2020 | 0 | 3 |
| 2021 | 0 | 1 |
| 2022 | 2 | 1 |
| 2023 | 2 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Subtituted sulfonylurea and sulfoximineurea derivatives14 Apr 2026US 12,599,616 B2Zydus Lifesciences Limited
- Sulfonamide carboxamide compounds3 Oct 2023US 11,773,058 B2Inflazome Limited
- Compounds11 Apr 2023US 11,623,922 B2Inflazome Limited
- Sulfonamide carboxamide compounds6 Dec 2022US 11,518,739 B2Inflazome Limited
- TRNA synthetase inhibitors1 Mar 2022US 11,261,201 B2President and Fellows of Harvard College
- Metabotropic glutamate receptor positive allosteric modulators (pams) and uses thereof5 Jun 2025US 2025/0179000 A1Sanford Burnham Prebys Medical Discovery Institute
- Novel subtituted sulfonylurea and sulfoximineurea derivatives30 Mar 2023US 2023/0096220 A1Zydus Lifesciences Limited
- Trna synthetase inhibitors30 Mar 2023US 2023/0102879 A1President and Fellows of Harvard College
- Novel sulfoneurea compounds7 Apr 2022US 2022/0106288 A1Inflazome Limited
- Trna synthetase inhibitors25 Feb 2021US 2021/0053997 A1President and Fellows of Harvard College
Most cited
By later US patents
- Benzoyl-substituted phenylalanineamides74US 7,687,435 B2BASF SE · 2010
- Amino acid derivative anticonvulsant44US 5,378,729 AResearch Corporation Technologies, Inc. · 1995
- Amino acid derivative anticonvulsant44US 5,654,301 AResearch Corporation Technologies, Inc. · 1997
- Sulfonyl urea and carbamate ACAT inhibitors41US 5,981,595 AWarner-Lambert Company · 1999
- Cycloalkyl inhibitors of potassium channel function24US 7,202,253 B2Bristol-Myers Squibb Company · 2007